Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

about

Oligometastases of Gastrointestinal Cancer Origin.

P2860

Q54901248-BA802AB1-C0B1-4DAC-8194-25EF279CC514

P2860

Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

Item

http://www.wikidata.org/entity/Q38985204

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Current management of liver me ...... w challenge of EORTC and JCOG.

@en

type

Item

label

Current management of liver me ...... w challenge of EORTC and JCOG.

@en

prefLabel

Current management of liver me ...... w challenge of EORTC and JCOG.

@en

P1476

Current management of liver me ...... ew challenge of EORTC and JCOG

@en

P2093

Anna Dorothea Wagner

http://www.w3.org/2001/XMLSchema#string

EORTC GITCG Group and JCOG SCGC Group

http://www.w3.org/2001/XMLSchema#string

Florian Lordick

http://www.w3.org/2001/XMLSchema#string

Franco Roviello

http://www.w3.org/2001/XMLSchema#string

Kohei Shitara

http://www.w3.org/2001/XMLSchema#string

Markus Moehler

http://www.w3.org/2001/XMLSchema#string

Masanori Terashima

http://www.w3.org/2001/XMLSchema#string

Masanori Tokunaga

http://www.w3.org/2001/XMLSchema#string

Michel Ducreux

http://www.w3.org/2001/XMLSchema#string

Murielle Mauer

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Patterns of initial recurrence in completely resected gastric adenocarcinoma.

Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?

Recent advances in multimodal treatment for gastric cancer: a review.

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

P2888

s10120-017-0696-7

P304

904-912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10120-017-0696-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kozo Kataoka

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083404028

http://www.w3.org/2001/XMLSchema#string

P698

28150070

http://www.w3.org/2001/XMLSchema#string

Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

about

P2860

P2860

Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698